Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.6900
+0.0700 (11.29%)
Oct 3, 2025, 3:58 PM EDT
Pharma-Bio Serv Revenue
Pharma-Bio Serv had revenue of $1.96M in the quarter ending July 31, 2025, a decrease of -18.82%. This brings the company's revenue in the last twelve months to $9.18M, down -14.75% year-over-year. In the fiscal year ending October 31, 2024, Pharma-Bio Serv had annual revenue of $9.51M, down -43.99%.
Revenue (ttm)
9.18M
Revenue Growth
-14.75%
P/S Ratio
1.72
Revenue / Employee
122.46K
Employees
75
Market Cap
15.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 9.51M | -7.47M | -43.99% |
Oct 31, 2023 | 16.98M | -2.42M | -12.48% |
Oct 31, 2022 | 19.40M | -716.45K | -3.56% |
Oct 31, 2021 | 20.12M | -1.45M | -6.72% |
Oct 31, 2020 | 21.56M | 2.06M | 10.55% |
Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
AMJ Global Technology | 39.00 |
Pharma-Bio Serv News
- 18 days ago - Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025 - Accesswire
- 3 months ago - Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025 - Accesswire
- 7 months ago - Pharma-Bio Serv reports revenue of $2.5 million for quarter ended January 31, 2025 - Seeking Alpha
- 7 months ago - Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025 - Accesswire
- 8 months ago - Pharma-Bio Serv reports FY results - Seeking Alpha
- 8 months ago - Pharma-Bio Serv declares $0.075 dividend - Seeking Alpha
- 8 months ago - Pharma-Bio Serv Announces Full Year Results - Accesswire
- 8 months ago - Pharma-Bio Serv Announces Special Dividend - Accesswire